Close Menu

Microfluidic Systems

Pursuing what it sees as a burgeoning interest from investors and potential partners in increasingly smaller molecular diagnostic platforms, PositiveID has begun developing a battery-operated, handheld version of Dragonfly, its benchtop, cassette-based molecular testing system, t

Roche wins multiple US patents; Life Tech, Stanford, Medical Diagnostic Labs, PositiveID, and STMicroelectronics also awarded US patents.

The IP is assigned to Microfluidic Systems, which applied for the patent in September 2005 and is in the process of being acquired by PositiveID in a deal worth up to $8.2 million.

The deal, worth as much as $8.2 million, is expected to enable the medical-tech firm to expand into the biodefense and clinical diagnostics markets via MFSI's multiplexed molecular assays and automated, PCR-based sample-to-answer technology.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.